riliprubart
riliprubart: 2 clinical trials tracked.
riliprubart evidence translation
What we can confirm
2 tracked trials
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about riliprubart, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (2)
A Phase 3, Randomized, Double-blind, Study Evaluating Efficacy and Safety of Riliprubart Versus Intravenous Immunoglobulin (IVIg) in Participants With Chronic Inflammatory Demyelinating Polyneuropathy
Primary endpoint: Percentage of participants experiencing a response
InterventionalRandomizedquadruple160 targetStarted 2024-08Completion 2029-0150 sites · Argentina, Belgium, Brazil, Canada…Sanofi
A Phase 3, Double-blind, Placebo-controlled Study Evaluating Efficacy and Safety of Riliprubart in Participants With Refractory Chronic Inflammatory Demyelinating Polyneuropathy
Primary endpoint: Percentage of participants experiencing a response
InterventionalRandomizedquadruple109 enrolledStarted 2024-07Completion 2027-1050 sites · Argentina, Belgium, Brazil, Bulgaria…Sanofi